The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Waldenstrom Macroglobulinemia

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Waldenstrom Macroglobulinemia


Psychiatry related information on Waldenstrom Macroglobulinemia


High impact information on Waldenstrom Macroglobulinemia


Chemical compound and disease context of Waldenstrom Macroglobulinemia


Biological context of Waldenstrom Macroglobulinemia


Anatomical context of Waldenstrom Macroglobulinemia


Gene context of Waldenstrom Macroglobulinemia


Analytical, diagnostic and therapeutic context of Waldenstrom Macroglobulinemia


  1. BCL2 accelerates inflammation-induced BALB/c plasmacytomas and promotes novel tumors with coexisting T(12;15) and T(6;15) translocations. Silva, S., Kovalchuk, A.L., Kim, J.S., Klein, G., Janz, S. Cancer Res. (2003) [Pubmed]
  2. Amyloid A in systemic amyloidosis associated with cancer. Husby, G., Marhaug, G., Sletten, K. Cancer Res. (1982) [Pubmed]
  3. Paraneoplastic neurologic syndromes: pathogenesis and physiopathology. Dalmau, J., Gultekin, H.S., Posner, J.B. Brain Pathol. (1999) [Pubmed]
  4. Mapping IgG epitopes bound by rheumatoid factors from immunized controls identifies disease-specific rheumatoid factors produced by patients with rheumatoid arthritis. Bonagura, V.R., Agostino, N., Børretzen, M., Thompson, K.M., Natvig, J.B., Morrison, S.L. J. Immunol. (1998) [Pubmed]
  5. The internal image of IgG in cross-reactive anti-idiotypic antibodies against human rheumatoid factors. Fong, S., Gilbertson, T.A., Carson, D.A. J. Immunol. (1983) [Pubmed]
  6. A human monoclonal IgG1 with anti-idiotypic activity against anti-human thyroglobulin autoantibody. Zouali, M., Fine, J.M., Eyquem, A. J. Immunol. (1984) [Pubmed]
  7. Abnormal cortisol binding in a case of Waldenström's macroglobulinemia. Benvenga, S., Trimarchi, F., Barbera, C., Consolo, F. N. Engl. J. Med. (1980) [Pubmed]
  8. Immunochemical similarities between monoclonal antibacterial Waldenstrom's macroglobulins and monoclonal anti-DNA lupus autoantibodies. Naparstek, Y., Duggan, D., Schattner, A., Madaio, M.P., Goni, F., Frangione, B., Stollar, B.D., Kabat, E.A., Schwartz, R.S. J. Exp. Med. (1985) [Pubmed]
  9. Monomeric (7S) IgM found in the serum of rheumatoid arthritis patients share idiotypes with pentameric (19S) monoclonal rheumatoid factors. Bonagura, V.R., Mendez, L., Agostino, N., Pernis, B. J. Clin. Invest. (1987) [Pubmed]
  10. Increased adenosine deaminase activity in peripheral lymphocytes in Waldenström's macroglobulinemia. Sidi, Y., Boer, P., Pick, I., Pinkhas, J., Sperling, O. Lancet (1979) [Pubmed]
  11. Treatment of Waldenstrom macroglobulinemia with 2-chlorodeoxyadenosine. Dimopoulos, M.A., Kantarjian, H., Estey, E., O'Brien, S., Delasalle, K., Keating, M.J., Freireich, E.J., Alexanian, R. Ann. Intern. Med. (1993) [Pubmed]
  12. Multicenter, randomized comparative trial of fludarabine and the combination of cyclophosphamide-doxorubicin-prednisone in 92 patients with Waldenström macroglobulinemia in first relapse or with primary refractory disease. Leblond, V., Lévy, V., Maloisel, F., Cazin, B., Fermand, J.P., Harousseau, J.L., Remenieras, L., Porcher, R., Gardembas, M., Marit, G., Deconinck, E., Desablens, B., Guilhot, F., Philippe, G., Stamatoullas, A., Guibon, O. Blood (2001) [Pubmed]
  13. Combination chemotherapy (M-2) protocol (BCNU, cyclophosphamide, vincristine, melphalan, and prednisone) for Waldenström macroglobulinemia: preliminary report. Case, D.C. Blood (1982) [Pubmed]
  14. Treatment of Waldenstrom's macroglobulinemia with thalidomide. Dimopoulos, M.A., Zomas, A., Viniou, N.A., Grigoraki, V., Galani, E., Matsouka, C., Economou, O., Anagnostopoulos, N., Panayiotidis, P. J. Clin. Oncol. (2001) [Pubmed]
  15. Immunoglobulins as nucleating proteins in the gallbladder bile of patients with cholesterol gallstones. Harvey, P.R., Upadhya, G.A., Strasberg, S.M. J. Biol. Chem. (1991) [Pubmed]
  16. Src tyrosine kinase regulates adhesion and chemotaxis in Waldenstrom macroglobulinemia. Ngo, H.T., Azab, A.K., Farag, M., Jia, X., Melhem, M.M., Runnels, J., Roccaro, A.M., Azab, F., Sacco, A., Leleu, X., Anderson, K.C., Ghobrial, I.M. Clin. Cancer Res. (2009) [Pubmed]
  17. Potential impact of a single nucleotide polymorphism in the hyaluronan synthase 1 gene in Waldenstrom's macroglobulinemia. Adamia, S., Treon, S.P., Reiman, T., Tournilhac, O., McQuarrie, C., Mant, M.J., Belch, A.R., Pilarski, L.M. Clinical lymphoma. (2005) [Pubmed]
  18. Waldenström's macroglobulinemia and myasthenia gravis. Bartoloni, C., Scoppetta, C., Flamini, G., Guidi, L., Bartoccioni, E., Lambiase, M., Gambassi, G., Terranova, T. Journal of clinical & laboratory immunology. (1981) [Pubmed]
  19. B-lymphocyte stimulator (BLyS) stimulates immunoglobulin production and malignant B-cell growth in Waldenstrom macroglobulinemia. Elsawa, S.F., Novak, A.J., Grote, D.M., Ziesmer, S.C., Witzig, T.E., Kyle, R.A., Dillon, S.R., Harder, B., Gross, J.A., Ansell, S.M. Blood (2006) [Pubmed]
  20. Subcellular localization of sulfated glucuronic acid-containing glycolipids reacting with anti-myelin-associated glycoprotein antibody. Kohriyama, T., Kusunoki, S., Ariga, T., Yoshino, J.E., DeVries, G.H., Latov, N., Yu, R.K. J. Neurochem. (1987) [Pubmed]
  21. Perivascular siderophages in skeletal muscle from a patient with diabetic neuropathy. Davis, D.G., Markesbery, W.R. Acta Neuropathol. (1992) [Pubmed]
  22. Effects of combretastatin A-4 prodrug against a panel of malignant human B-lymphoid cell lines. Nabha, S.M., Wall, N.R., Mohammad, R.M., Pettit, G.R., Al-Katib, A.M. Anticancer Drugs (2000) [Pubmed]
  23. Sequential technetium-99m sulfur colloid/indium-111 white blood cell imaging in macroglobulinemia of Waldenstrom. Fink-Bennett, D., Balon, H.R., Irwin, R. Clinical nuclear medicine. (1990) [Pubmed]
  24. Elevated levels of interleukin-1 beta (IL-1 beta) and IL-6 in serum and increased production of IL-1 beta mRNA in lymph nodes of patients with polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes (POEMS) syndrome. Gherardi, R.K., Bélec, L., Fromont, G., Divine, M., Malapert, D., Gaulard, P., Degos, J.D. Blood (1994) [Pubmed]
  25. CD52 expression in Waldenstrom's macroglobulinemia: implications for alemtuzumab therapy and response assessment. Owen, R.G., Hillmen, P., Rawstron, A.C. Clinical lymphoma. (2005) [Pubmed]
  26. CD5, CD10, and CD23 expression in Waldenstrom's macroglobulinemia. Hunter, Z.R., Branagan, A.R., Manning, R., Patterson, C.J., Santos, D.D., Tournilhac, O., Dorfman, D.M., Treon, S.P. Clinical lymphoma. (2005) [Pubmed]
  27. Clonotypic IgM V/D/J sequence analysis in Waldenstrom macroglobulinemia suggests an unusual B-cell origin and an expansion of polyclonal B cells in peripheral blood. Kriangkum, J., Taylor, B.J., Treon, S.P., Mant, M.J., Belch, A.R., Pilarski, L.M. Blood (2004) [Pubmed]
  28. Myopathy and paraproteinemia with serum IgM binding to a high-molecular-weight muscle fiber surface protein. al-Lozi, M.T., Pestronk, A., Yee, W.C., Flaris, N. Ann. Neurol. (1995) [Pubmed]
  29. Successful treatment of human Waldenström's macroglobulinemia with combination biological and chemotherapy agents. Mohammad, R.M., al-Katib, A., Pettit, G.R., Sensenbrenner, L.L. Cancer Res. (1994) [Pubmed]
  30. Acute renal failure in primary macroglobulinemia with small-molecule IgM. Matsumoto, J., Yasaka, T., Ohya, I., Ohtani, H. Arch. Intern. Med. (1985) [Pubmed]
  31. IL-1beta expression in IgM monoclonal gammopathy and its relationship to multiple myeloma. Donovan, K.A., Lacy, M.Q., Gertz, M.A., Lust, J.A. Leukemia (2002) [Pubmed]
  32. The monoclonal gammopathies. Kyle, R.A. Clin. Chem. (1994) [Pubmed]
WikiGenes - Universities